글로벌 세버병 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 세버병 치료 시장

세버병 치료 시장은 2021-2028년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 시장이 5%의 CAGR로 성장할 것으로 분석합니다.

세버병은 발꿈치 불편함을 유발하는 청소년에게 흔한 질환입니다. 발꿈치의 성장판에 압력을 가하는 충격이 큰 스포츠와 활동은 통증을 악화시킵니다. 어린이와 청소년은 뼈를 연결하는 연골 조각인 성장판을 가지고 있습니다. 성장판은 나이가 들면서 뼈로 굳어집니다. 세버병은 질병이라기보다는 부상입니다. 시간이 지나면서 어린이는 이 병을 극복합니다. 그동안 휴식, 진통제, 올바른 신발을 신으면 일반적으로 증상을 완화하는 데 충분합니다. 이 질환의 증상에는 발꿈치 뒤쪽이나 아래쪽의 통증, 달리거나 점프하거나 평소 활동이나 스포츠에 참여하는 데 어려움, 발가락으로 걷기, 발꿈치 측면을 압박할 때의 통증, 절뚝거림 및 피로가 있습니다. 발꿈치 골단염은 이 질환의 또 다른 이름입니다.

세버병 유병률의 증가와 비만 발생률의 증가 는 시장 성장률에 영향을 미치는 주요 요인입니다. 또한, 정부 자금 지원의 증가와 질병과 이용 가능한 치료법에 대한 인식을 확산하기 위한 공공 및 민간 기관의 이니셔티브 증가는 세버병 치료 시장을 확대할 요인입니다. 의료비 지출 증가와 새로운 치료법에 대한 수요 증가를 포함한 다른 요인은 시장 성장률에 긍정적인 영향을 미칠 것입니다.

Rise in the research and development activities and emerging markets will provide beneficial opportunities for the Sever’s disease treatment market in the forecast period of 2021-2028.

However, high cost of the treatment and complications associated with the disease are the factors that will hinder the market growth. Lack of awareness about preventive measures will further challenge the Sever’s disease treatment market in the forecast period mentioned above.

This Sever’s disease treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Sever’s disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Sever’s Disease Treatment Market Scope and Market Size

The Sever’s disease treatment market is segmented on the basis of type, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the Sever’s disease treatment market is segmented into acute and chronic.
• On the basis of treatment, the Sever’s disease treatment market is segmented into NSAIDs (non-steroidal anti-inflammatory drugs), immobilization, physical therapy, ice therapy, and others.
• On the basis of diagnosis, the Sever’s disease treatment market is segmented into x-ray, squeeze test, magnetic resonance imaging (MRI) and others.
• On the basis of symptoms, the Sever’s disease treatment market is segmented into pain in the back or bottom of the heel, difficulty running, jumping or participating in usual activities or sports, walking on toes, pain when the sides of the heel are squeezed, limping, tiredness and others.
• On the basis of dosage, the Sever’s disease treatment market is segmented into tablet, injection and others.
• On the basis of route of administration, the Sever’s disease treatment market is segmented into oral, injectable and others.
• On the basis of end-users, the Sever’s disease treatment market is segmented into clinic, hospital and others.
• The Sever’s disease treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Sever’s Disease Treatment Market Country Level Analysis

Sever’s disease treatment market is analyzed and market size information is provided by the country, type, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Sever’s disease treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the Sever’s disease treatment market due to presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Sever’s disease treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Sever’s Disease Treatment Market Share Analysis

세버병 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 임상 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선입니다. 위에 제공된 데이터 포인트는 세버병 치료 시장 조사와 관련된 회사의 초점에만 관련이 있습니다.

세버병 치료 시장 보고서에 포함된 주요 기업으로는 Pfizer Inc., GlaxoSmithKline plc, Bayer AG, Boehringer Ingelheim International GmbH., AstraZeneca, Johnson & Johnson Private Limited, Horizon Therapeutics plc., Sanofi, Novartis AG, Sun Pharmaceutical Industries Ltd., Reckitt Benckiser Group PLC, Cipla Inc., Sumitomo Dainippon Pharma Co., Ltd., LEO Pharma A/S, F. Hoffmann-La Roche Ltd., AbbVie Inc., Zyla Life Sciences, Mylan NV, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Lonza, Dr. Reddy's Laboratories Ltd., Iroko Pharmaceuticals Inc., Assertio Holdings, Inc. 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-67221